van HeckeO, AustinSK, KhanRA, et al.: Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain, 2014; 155:654–662.
FinnerupNB, AttalN, HaroutounianS, et al.: Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol, 2015; 14:162–173.
5.
CooperTE, ChenJ, WiffenPJ, et al.: Morphine for chronic neuropathic in adults. Cochrane Database Syst Rev, 2017:CD011669.
6.
GaskellH, DerryS, StannardC, et al.: Oxycodone for neuropathic pain in adults. Cochrane Database Syst Rev, 2016:CD010692.
7.
AiyerR, MehtaN, GungorS, et al.: A systematic review of NMDA receptor antagonists for treatment of neuropathic pain in clinical practice. Clin J Pain, 2017; 34:450–467.
8.
O'ConnorAB, DworkinRH: Treatment of neuropathic pain: An overview of recent guidelines. Am J Med, 2009; 122:S22–S32.
9.
MooreRA, ChiCC, WiffemPJ, et al.: Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database Syst Rev, 2015:CD010902.
10.
StannardC, GaskellH, DerryS, et al.: Hydromorphone for neuropathic pain in adults. Cochrane Database Syst Rev, 2016:CD011604.
11.
DerryS, StannardC, ColeP, et al.: Fentanyl for neuropathic pain in adults. Cochrane Database Syst Rev, 2016; 10:CD011605.
12.
McNicolED, FergusonMC, SchumannR: Methadone for neuropathic pain in adults. Cochrane Database Syst Rev, 2017; 5:CD012499.
13.
DuehmkeRM, DerryS, WiffenPJ, et al.: Tramadol for neuropathic pain in adults. Cochrane Database Syst Rev, 2017:CD003726.
14.
BaronR, KernU, MullerM, et al.: Effectiveness and tolerability of a moderate dose of tapentadol prolonged release for managing severe, chronic low back pain with a neuropathic component: An open-label continuation arm of a randomized phase 3b study. Pain Pract, 2015; 15:471–486.
15.
BaronR, Martin-MolaE, MullerM, et al.: Effectiveness and safety of tapentadol prolonged release (PR) versus a combination of tapentadol PR and pregabalin for the management of severe, chronic low back pain with a neuropathic component: A randomized, double-blind, phase 3b study. Pain Pract, 2015; 15:455–470.
16.
VinikA, ShapiroDY, RauschkolbC, et al.: A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy. Diabetes Care, 2014; 37:2302–2309.
17.
SchwartzS, EtropolskiM, ShapiroDY, et al.: Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: Results of a randomized-withdrawal, placebo-controlled trial. Curr Med Res Opin, 2011; 27:151–162.
18.
WiffenPJ, DerryS, MooreRA, et al.: Buprenorphine for neuropathic pain in adults. Cochrane Database Syst Rev, 2015:CD011603.
19.
SmithLJ, Krugner-HigbyL, ClarkM, et al.: A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain. Comp Med, 2003; 53:280–287.
20.
WiffenPJ, KnaggsR, DerryS, et al.: Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults. Cochrane Database Syst Rev, 2016; 12:CD012227.
